Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. Supervision of the Conduct of a Clinical Investigation
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. Protecting the Rights, Safety, and Welfare of Study Subjects
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
- Jan 16
- Jan 11
- Jan 10
- Dec 16
- Dec 13
- Dec 06
- Dec 06
- Dec 05
- Dec 05
- Nov 23
Tulevat kliiniset tutkimukset
-
NCT02408861RekrytointiHIV-infektio Edistynyt pahanlaatuinen kiinteä kasvain Kaposin sarkooma Keuhkokarsinooma Metastaattinen pahanlaatuinen kiinteä kasvain Kiinteä kasvain, jota ei voida leikata Anaalikarsinooma Toistuva klassinen Hodgkin-lymfooma Tulenkestävä klassinen Hodgkin-lymfooma
-
NCT05052216RekrytointiLasten obstruktiivinen uniapnea
-
NCT05710536RekrytointiTerve Vagina Laxity
-
NCT05709327Ei vielä rekrytointia
-
NCT01604512Rekrytointi
-
NCT03328078RekrytointiTulenkestävä hematologinen pahanlaatuisuus Uusiutunut hematologinen pahanlaatuisuus
-
NCT05711251Ei vielä rekrytointiaFyysinen passiivisuus
-
NCT05711056Ei vielä rekrytointiaOpioidien käyttö Opioidien väärinkäyttö
-
NCT05710887Ei vielä rekrytointiaItsemurha-ajattelu Masennustila Hoitoa kestävä masennus
Clinical Research Jobs
-
Associate CDM Programmer
-
Sr Procurement Program Manager
-
Associate Director, Market Access Communications
-
CRA (Level II) - Transferable Skills (APAC)
-
Research Assoc II Evidera
-
Sr Programmer Analyst II - SDTM, TLF, ADAM- Open for Remote/Flex/Officebase
-
Sr Clin Data Team Lead
-
Senior Biostatistician - Taiwan
-
UNC Chapel Hill STEM & All Majors Virtual Career Fair Attendee
-
University of Kansas 2023 Career & Internship Expo